DPT Vaccination
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Pneumococcal Vaccination Market Research Report 2024
1 Pneumococcal Vaccination Market Overview
1.1 Product Overview and Scope of Pneumococcal Vaccination
1.2 Pneumococcal Vaccination Segment by Type
1.2.1 Global Pneumococcal Vaccination Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 PPSV 23
1.2.3 PCV 7/13
1.2.4 PCV 10
1.3 Pneumococcal Vaccination Segment by Application
1.3.1 Global Pneumococcal Vaccination Sales Comparison by Application: (2022-2028)
1.3.2 Child
1.3.3 Adult
1.4 Global Pneumococcal Vaccination Market Size Estimates and Forecasts
1.4.1 Global Pneumococcal Vaccination Revenue 2017-2028
1.4.2 Global Pneumococcal Vaccination Sales 2017-2028
1.4.3 Pneumococcal Vaccination Market Size by Region: 2017 Versus 2021 Versus 2028
2 Pneumococcal Vaccination Market Competition by Manufacturers
2.1 Global Pneumococcal Vaccination Sales Market Share by Manufacturers (2017-2022)
2.2 Global Pneumococcal Vaccination Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Pneumococcal Vaccination Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Pneumococcal Vaccination Manufacturing Sites, Area Served, Product Type
2.5 Pneumococcal Vaccination Market Competitive Situation and Trends
2.5.1 Pneumococcal Vaccination Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pneumococcal Vaccination Players Market Share by Revenue
2.5.3 Global Pneumococcal Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pneumococcal Vaccination Retrospective Market Scenario by Region
3.1 Global Pneumococcal Vaccination Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Pneumococcal Vaccination Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Pneumococcal Vaccination Market Facts & Figures by Country
3.3.1 North America Pneumococcal Vaccination Sales by Country
3.3.2 North America Pneumococcal Vaccination Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Pneumococcal Vaccination Market Facts & Figures by Country
3.4.1 Europe Pneumococcal Vaccination Sales by Country
3.4.2 Europe Pneumococcal Vaccination Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pneumococcal Vaccination Market Facts & Figures by Region
3.5.1 Asia Pacific Pneumococcal Vaccination Sales by Region
3.5.2 Asia Pacific Pneumococcal Vaccination Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Pneumococcal Vaccination Market Facts & Figures by Country
3.6.1 Latin America Pneumococcal Vaccination Sales by Country
3.6.2 Latin America Pneumococcal Vaccination Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pneumococcal Vaccination Market Facts & Figures by Country
3.7.1 Middle East and Africa Pneumococcal Vaccination Sales by Country
3.7.2 Middle East and Africa Pneumococcal Vaccination Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pneumococcal Vaccination Historic Market Analysis by Type
4.1 Global Pneumococcal Vaccination Sales Market Share by Type (2017-2022)
4.2 Global Pneumococcal Vaccination Revenue Market Share by Type (2017-2022)
4.3 Global Pneumococcal Vaccination Price by Type (2017-2022)
5 Global Pneumococcal Vaccination Historic Market Analysis by Application
5.1 Global Pneumococcal Vaccination Sales Market Share by Application (2017-2022)
5.2 Global Pneumococcal Vaccination Revenue Market Share by Application (2017-2022)
5.3 Global Pneumococcal Vaccination Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Pneumococcal Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer Pneumococcal Vaccination Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Pneumococcal Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.2.4 GSK Pneumococcal Vaccination Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 MSD
6.3.1 MSD Corporation Information
6.3.2 MSD Description and Business Overview
6.3.3 MSD Pneumococcal Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.3.4 MSD Pneumococcal Vaccination Product Portfolio
6.3.5 MSD Recent Developments/Updates
6.4 Sanofipasteur
6.4.1 Sanofipasteur Corporation Information
6.4.2 Sanofipasteur Description and Business Overview
6.4.3 Sanofipasteur Pneumococcal Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sanofipasteur Pneumococcal Vaccination Product Portfolio
6.4.5 Sanofipasteur Recent Developments/Updates
6.5 CDIBP
6.5.1 CDIBP Corporation Information
6.5.2 CDIBP Description and Business Overview
6.5.3 CDIBP Pneumococcal Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.5.4 CDIBP Pneumococcal Vaccination Product Portfolio
6.5.5 CDIBP Recent Developments/Updates
6.6 WALVAX
6.6.1 WALVAX Corporation Information
6.6.2 WALVAX Description and Business Overview
6.6.3 WALVAX Pneumococcal Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.6.4 WALVAX Pneumococcal Vaccination Product Portfolio
6.6.5 WALVAX Recent Developments/Updates
6.7 Sinovac
6.6.1 Sinovac Corporation Information
6.6.2 Sinovac Description and Business Overview
6.6.3 Sinovac Pneumococcal Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sinovac Pneumococcal Vaccination Product Portfolio
6.7.5 Sinovac Recent Developments/Updates
6.8 Bio Kangtai
6.8.1 Bio Kangtai Corporation Information
6.8.2 Bio Kangtai Description and Business Overview
6.8.3 Bio Kangtai Pneumococcal Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Bio Kangtai Pneumococcal Vaccination Product Portfolio
6.8.5 Bio Kangtai Recent Developments/Updates
7 Pneumococcal Vaccination Manufacturing Cost Analysis
7.1 Pneumococcal Vaccination Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pneumococcal Vaccination
7.4 Pneumococcal Vaccination Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pneumococcal Vaccination Distributors List
8.3 Pneumococcal Vaccination Customers
9 Pneumococcal Vaccination Market Dynamics
9.1 Pneumococcal Vaccination Industry Trends
9.2 Pneumococcal Vaccination Market Drivers
9.3 Pneumococcal Vaccination Market Challenges
9.4 Pneumococcal Vaccination Market Restraints
10 Global Market Forecast
10.1 Pneumococcal Vaccination Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pneumococcal Vaccination by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Pneumococcal Vaccination by Type (2023-2028)
10.2 Pneumococcal Vaccination Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pneumococcal Vaccination by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Pneumococcal Vaccination by Application (2023-2028)
10.3 Pneumococcal Vaccination Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pneumococcal Vaccination by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Pneumococcal Vaccination by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Pneumococcal Vaccination Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
Table 2. Global Pneumococcal Vaccination Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
Table 3. Global Pneumococcal Vaccination Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Pneumococcal Vaccination Market Competitive Situation by Manufacturers in 2021
Table 5. Global Pneumococcal Vaccination Sales (Units) of Key Manufacturers (2017-2022)
Table 6. Global Pneumococcal Vaccination Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Pneumococcal Vaccination Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Pneumococcal Vaccination Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Pneumococcal Vaccination Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Pneumococcal Vaccination Manufacturing Sites and Area Served
Table 11. Manufacturers Pneumococcal Vaccination Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pneumococcal Vaccination by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Vaccination as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pneumococcal Vaccination Sales by Region (2017-2022) & (Units)
Table 16. Global Pneumococcal Vaccination Sales Market Share by Region (2017-2022)
Table 17. Global Pneumococcal Vaccination Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Pneumococcal Vaccination Revenue Market Share by Region (2017-2022)
Table 19. North America Pneumococcal Vaccination Sales by Country (2017-2022) & (Units)
Table 20. North America Pneumococcal Vaccination Sales Market Share by Country (2017-2022)
Table 21. North America Pneumococcal Vaccination Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Pneumococcal Vaccination Revenue Market Share by Country (2017-2022)
Table 23. Europe Pneumococcal Vaccination Sales by Country (2017-2022) & (Units)
Table 24. Europe Pneumococcal Vaccination Sales Market Share by Country (2017-2022)
Table 25. Europe Pneumococcal Vaccination Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Pneumococcal Vaccination Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Pneumococcal Vaccination Sales by Region (2017-2022) & (Units)
Table 28. Asia Pacific Pneumococcal Vaccination Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Pneumococcal Vaccination Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Pneumococcal Vaccination Revenue Market Share by Region (2017-2022)
Table 31. Latin America Pneumococcal Vaccination Sales by Country (2017-2022) & (Units)
Table 32. Latin America Pneumococcal Vaccination Sales Market Share by Country (2017-2022)
Table 33. Latin America Pneumococcal Vaccination Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Pneumococcal Vaccination Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Pneumococcal Vaccination Sales by Country (2017-2022) & (Units)
Table 36. Middle East and Africa Pneumococcal Vaccination Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Pneumococcal Vaccination Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Pneumococcal Vaccination Revenue Market Share by Country (2017-2022)
Table 39. Global Pneumococcal Vaccination Sales by Type (2017-2022) & (Units)
Table 40. Global Pneumococcal Vaccination Sales Market Share by Type (2017-2022)
Table 41. Global Pneumococcal Vaccination Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Pneumococcal Vaccination Revenue Share by Type (2017-2022)
Table 43. Global Pneumococcal Vaccination Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Pneumococcal Vaccination Sales (Units) by Application (2017-2022)
Table 45. Global Pneumococcal Vaccination Sales Market Share by Application (2017-2022)
Table 46. Global Pneumococcal Vaccination Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Pneumococcal Vaccination Revenue Share by Application (2017-2022)
Table 48. Global Pneumococcal Vaccination Price by Application (2017-2022) & (US$/Unit)
Table 49. Pfizer Corporation Information
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer Pneumococcal Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Pfizer Pneumococcal Vaccination Product
Table 53. Pfizer Recent Developments/Updates
Table 54. GSK Corporation Information
Table 55. GSK Description and Business Overview
Table 56. GSK Pneumococcal Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. GSK Pneumococcal Vaccination Product
Table 58. GSK Recent Developments/Updates
Table 59. MSD Corporation Information
Table 60. MSD Description and Business Overview
Table 61. MSD Pneumococcal Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. MSD Pneumococcal Vaccination Product
Table 63. MSD Recent Developments/Updates
Table 64. Sanofipasteur Corporation Information
Table 65. Sanofipasteur Description and Business Overview
Table 66. Sanofipasteur Pneumococcal Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Sanofipasteur Pneumococcal Vaccination Product
Table 68. Sanofipasteur Recent Developments/Updates
Table 69. CDIBP Corporation Information
Table 70. CDIBP Description and Business Overview
Table 71. CDIBP Pneumococcal Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. CDIBP Pneumococcal Vaccination Product
Table 73. CDIBP Recent Developments/Updates
Table 74. WALVAX Corporation Information
Table 75. WALVAX Description and Business Overview
Table 76. WALVAX Pneumococcal Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. WALVAX Pneumococcal Vaccination Product
Table 78. WALVAX Recent Developments/Updates
Table 79. Sinovac Corporation Information
Table 80. Sinovac Description and Business Overview
Table 81. Sinovac Pneumococcal Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Sinovac Pneumococcal Vaccination Product
Table 83. Sinovac Recent Developments/Updates
Table 84. Bio Kangtai Corporation Information
Table 85. Bio Kangtai Description and Business Overview
Table 86. Bio Kangtai Pneumococcal Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Bio Kangtai Pneumococcal Vaccination Product
Table 88. Bio Kangtai Recent Developments/Updates
Table 89. Production Base and Market Concentration Rate of Raw Material
Table 90. Key Suppliers of Raw Materials
Table 91. Pneumococcal Vaccination Distributors List
Table 92. Pneumococcal Vaccination Customers List
Table 93. Pneumococcal Vaccination Market Trends
Table 94. Pneumococcal Vaccination Market Drivers
Table 95. Pneumococcal Vaccination Market Challenges
Table 96. Pneumococcal Vaccination Market Restraints
Table 97. Global Pneumococcal Vaccination Sales Forecast by Type (2023-2028) & (Units)
Table 98. Global Pneumococcal Vaccination Sales Market Share Forecast by Type (2023-2028)
Table 99. Global Pneumococcal Vaccination Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 100. Global Pneumococcal Vaccination Revenue Market Share Forecast by Type (2023-2028)
Table 101. Global Pneumococcal Vaccination Sales Forecast by Application (2023-2028) & (Units)
Table 102. Global Pneumococcal Vaccination Sales Market Share Forecast by Application (2023-2028)
Table 103. Global Pneumococcal Vaccination Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 104. Global Pneumococcal Vaccination Revenue Market Share Forecast by Application (2023-2028)
Table 105. Global Pneumococcal Vaccination Sales Forecast by Region (2023-2028) & (Units)
Table 106. Global Pneumococcal Vaccination Sales Market Share Forecast by Region (2023-2028)
Table 107. Global Pneumococcal Vaccination Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 108. Global Pneumococcal Vaccination Revenue Market Share Forecast by Region (2023-2028)
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pneumococcal Vaccination
Figure 2. Global Pneumococcal Vaccination Market Share by Type in 2021 & 2028
Figure 3. PPSV 23 Product Picture
Figure 4. PCV 7/13 Product Picture
Figure 5. PCV 10 Product Picture
Figure 6. Global Pneumococcal Vaccination Market Share by Application in 2021 & 2028
Figure 7. Child
Figure 8. Adult
Figure 9. Global Pneumococcal Vaccination Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Pneumococcal Vaccination Market Size (2017-2028) & (US$ Million)
Figure 11. Global Pneumococcal Vaccination Sales (2017-2028) & (Units)
Figure 12. Pneumococcal Vaccination Sales Share by Manufacturers in 2021
Figure 13. Global Pneumococcal Vaccination Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Pneumococcal Vaccination Players: Market Share by Revenue in 2021
Figure 15. Pneumococcal Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Pneumococcal Vaccination Sales Market Share by Region (2017-2022)
Figure 17. Global Pneumococcal Vaccination Sales Market Share by Region in 2021
Figure 18. Global Pneumococcal Vaccination Revenue Market Share by Region (2017-2022)
Figure 19. Global Pneumococcal Vaccination Revenue Market Share by Region in 2021
Figure 20. United States Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Pneumococcal Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Pneumococcal Vaccination by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Pneumococcal Vaccination
Figure 44. Manufacturing Process Analysis of Pneumococcal Vaccination
Figure 45. Pneumococcal Vaccination Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer GSK MSD Sanofipasteur CDIBP WALVAX Sinovac Bio Kangtai